全球皮肤疾病负担:全球疾病负担数据的启示
该研究基于全球疾病负担(GBD)2000至2021年数据,分析皮肤病的患病率、发病率、伤残调整生命年和伤残损失寿命年。结果显示,全球皮肤及皮下疾病患病率为25.7%,位居第六;YLDs率为每10万人年495.1,位居第八。最常见的疾病为除HIV外的性传播感染、真菌感染和痤疮。研究指出GBD数据存在低估和漏报,尤其在低收入和中等收入国家。
要点
- 全球皮肤及皮下疾病患病率25.7%,居疾病类别第六位。
- YLDs率为495.1/10万人年,疾病负担排名第八。
- 最常见为性传播感染(16.8%)、真菌感染(7.8%)和痤疮(3.0%)。
核心结论
- 皮肤疾病影响全球约三分之一人口,但GBD数据低估了真实负担。
- 需改进报告并纳入被忽视的疾病,通过全球合作应对。
研究设计与样本
- 分析GBD 2000至2021年皮肤病的患病率、发病率、DALYs和YLDs数据。
主要发现
- 全球皮肤及皮下疾病(排除STIs和皮肤癌)患病率为25.7%,排名第六。
- 全球YLDs率为495.1/10万人年,疾病负担排名第八。
- 最常见疾病为除HIV外的STIs(16.8%)、真菌感染(7.8%)和痤疮(3.0%)。
- 鳞状细胞癌、基底细胞癌和压疮患病率上升,特应性皮炎、疥疮和病毒感染略有下降。
- 痤疮、疥疮和特应性皮炎多见于青年,真菌感染、接触性皮炎和皮肤癌多见于老年人。
关键数值与推荐
- 女性STIs、痤疮和特应性皮炎患病率较高。
- 感染性皮肤病在撒哈拉以南非洲和热带地区更常见,慢性炎症性和肿瘤性疾病在高收入地区更常见。
临床怎么用
- 临床应关注不同年龄和地区的疾病谱差异,优化资源分配。
- 需提高对漏报和误诊疾病的认识,加强全球协作改善数据质量。
局限性
- GBD仅纳入部分皮肤病,存在漏报和误诊导致的低估。
- 低收入和中等收入国家数据缺口大,缺乏可靠趋势和质量调整生命年估计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Skin diseases represent a major public health concern, affecting all demographics and imposing significant personal, economic and social burdens. OBJECTIVES: To assess the epidemiology and impact of skin diseases using the Global Burden of Disease (GBD) data, highlighting regional variations, knowledge gaps and areas for improvement. METHODS: GBD data on prevalence, incidence, disability-adjusted life years (DALYs) and years lived with disability (YLDs) for skin conditions from 2000 to 2021 were analysed. RESULTS: According to GBD 2021, the global prevalence of skin and subcutaneous diseases, excluding sexually transmitted infections (STIs) and skin cancers, was 25.7%, ranking sixth among the most prevalent disease categories worldwide. These conditions accounted for a global YLDs rate of 495.1 per 100,000 person-years, placing them eighth in terms of disease burden. Overall, the most prevalent conditions were STIs excluding HIV (16.8%), fungal infections (7.8%), and acne (3.0%). Squamous cell carcinoma, basal cell carcinoma and decubitus ulcers showed increasing prevalence, while atopic dermatitis, scabies and viral infections declined slightly. Acne, scabies and atopic dermatitis predominated in youth, whereas fungal infections, contact dermatitis and skin cancers predominated in older adults. Females showed higher prevalence of STIs, acne and atopic dermatitis. Infectious skin diseases were more common in Sub-Saharan Africa and tropical regions, while chronic inflammatory and neoplastic diseases predominated in high-income regions. CONCLUSIONS: Several limitations were identified. The GBD initiative only includes some dermatological diseases reflecting the difficulties in obtaining data because of the multitude of skin diseases with underreporting and misdiagnosis. There are significant gaps in data from low- and middle-income countries, a lack of reliable trends and inadequate quality-adjusted life year estimates considering cultural and social variations. The GBD initiative provides valuable insights but underestimates the true burden of skin diseases. Improved reporting and inclusion of neglected conditions are urgently needed through global collaboration among stakeholders. Skin diseases affect about one in three people worldwide. They are often visible—through scaling, colour changes, wounds or disfigurement—and can cause itching or pain, affecting daily life, mental and physical well‐being as well as social relationships. We used data from the Global Burden of Disease (GBD) study, a large international project that collects health information from many countries, to understand how common skin diseases are worldwide and how much they affect people’s lives. We analysed GBD data from 2000 to 2021, looking at how often skin diseases occur and how much disability they cause. The most common conditions were sexually transmitted infections, fungal infections and acne. Acne, scabies, and atopic dermatitis were more common in children and young adults, while fungal infections, contact dermatitis, and skin cancers were more frequent in older adults. Infectious skin diseases were more common in tropical regions and sub‐Saharan Africa, whereas chronic inflammatory skin diseases and skin cancers were more frequent in high‐income countries. However, the GBD study covers only some skin conditions. Many diseases are either underreported or misdiagnosed, especially in low‐ and middle‐income countries, meaning the true global burden is likely higher than reported. Overall, skin diseases are a major global health problem, but their frequency and impact are underestimated. This gap has been formally recognized by the adoption of the resolution “Skin Diseases as a Global Public Health Priority” at the 78th World Health Assembly, which aims to improve knowledge, prevention, care, and outcomes for people with skin diseases worldwide.
引用
- Naldi L, Cazzaniga S, Flohr C, et al. The worldwide burden of skin diseases: Lessons from the Global Burden of Disease data. J Eur Acad Dermatol Venereol. 2026. PMID: 42324974. doi:10.1111/jdv.70562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。